Patrick J. Crutcher
CIK: 0001754540
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Jul 31, 2026JSPR
Jasper Therapeutics, Inc.
Award(A)DirectStock Option (Right to Buy
7.5K shares- - Jul 20, 2026JSPR
Jasper Therapeutics, Inc.
Purchase(P)DirectNon-Voting Convertible Preferred Stock
888 shares- - Jul 16, 2026JSPR
Jasper Therapeutics, Inc.
Award(A)DirectStock Option (Right to Buy
15K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 31, 2026 |  JSPR Jasper Therapeutics, Inc. | Award(A) Stock Option (Right to Buy | 7,500 | - | - | Direct |
| Jul 20, 2026 | JSPR Jasper Therapeutics, Inc. | Purchase(P) Non-Voting Convertible Preferred Stock | 888 | - | - | Direct |
| Jul 16, 2026 | JSPR Jasper Therapeutics, Inc. | Award(A) Stock Option (Right to Buy | 15,000 | - | - | Direct |
1-3 of 3 transactions
About Crutcher Patrick J
Crutcher Patrick J (SEC CIK 0001754540) files insider reports with the SEC as Director of Jasper Therapeutics, Inc. (JSPR) and Director of Amanat Acquisition Corp. (AMAN).
Signal8 holds 4 ownership filings by Crutcher Patrick J (2 Form 3, 2 Form 4), filed between May 19, 2026 and Aug 4, 2026. Those filings report 3 transactions, from Jul 16, 2026 to Jul 31, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Crutcher Patrick J's filings is in REDWOOD CITY, CA.
Recent filings by Crutcher Patrick J
Other insiders filing for Jasper Therapeutics, Inc. (JSPR)
- WIGGANS THOMAS G, Director
- Lucas Svetlana, Director
- EMSTER KURT VON, Director
- Shizuru Judith Anne, Director
- Keenan Greg, Chief Medical Officer
- Ros Matthew E, Chief Operating Officer